Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUP62 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | JAG2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ZFYVE28 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | MFNG | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
mRNA | RNF150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | ZDHHC13 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | KLHL5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | SETD4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ABCA12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | GID8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |